SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-020088
Filing Date
2017-04-12
Accepted
2017-04-12 09:00:50
Documents
2
Period of Report
2017-04-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v464049_8k.htm 8-K 18428
2 EXHIBIT 99.1 v464049_ex99-1.htm EX-99.1 8442
  Complete submission text file 0001144204-17-020088.txt   28072
Mailing Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170 212-398-4627
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 333-191083 | Film No.: 17757090
SIC: 2834 Pharmaceutical Preparations